Esteatosis hepática no alcohólica: relación con el síndrome metabólico y los factores de riesgo cardiovascular em adolescentes obesos
DOI:
https://doi.org/10.5020/2421Palabras clave:
Adolescente, Obesidad Pediátrica, Hígado Gras, , Síndrome X Metabólico, Enfermedades CardiovascularesResumen
Objetivo: Evaluar la asociación entre la esteatosis hepática no alcohólica (EHNA), síndrome metabólico (SM) y factores de riesgo cardiovascular (FRCs) en adolescentes obesos. Métodos: Estudio observacional del tipo trasversal com abordaje cuantitativo realizado entre junio y agosto de 2011. Los voluntarios fueron seleccionados al azar y encaminados para evaluación clínica en el sector de endocrinología y cardiología del hospital de la Universidad Federal de Uberlandia. Participaron 34 adolescentes entre 14 y 19 años que estaban por encima Del percentil 95 de la curva de crecimiento. La EHNA fue analizada con la ultrasonografía. La SM y los FRCs fueron identificados a través de criterios de la International Diabetes Federtion. Resultados: La muestra fue constituida de 14 individuos del sexo masculino y 20 del sexo femenino con media de edad de 16,8±1,6años y media del índice de masa corporal (IMC) de 35,7±3,9. La ocurrencia de EHNA y SM fue del 76,5% (n=26) y 50% (n=17), respectivamente. El sexo masculino presentó mayor ocurrencia de EHNA (78,6%, n=11), SM (64,3%, n=09) y asociación de EHNA y SM (50%, n=07). Respecto a los FRCs, el 100% (n=34), 61,8% (n=21) y el 52,9% (n=18) de los adolescentes presentaron valores mayores de la circunferencia de cintura (CC), de la low-densitylipoprotein cholesterol (LDL-C) y tensión arterial sistólica (TAS), respectivamente, y el 52,9% (n=18) presentó bajos niveles de high-density lipoprotein cholesterol (HDL-C). Hubieron correlaciones entre SM y triglicérides, TAS y diastólica y HDL-C, y entre EHNA, IMC y CC. Conclusión: Se observó una elevada ocurrencia de EHNA, SM y FRCs en adolescentes obesos. Uma fuerte correlación fue observada entre EHNA y SM, y entre FRCs y EHNA y SM doi:10.5020/18061230.2014.p131Descargas
Citas
Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The Diagnosis and Management of Non-Alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatoloty. 2012;55(6):2005-23.
Tiniakos DG, Vos MB, Brunt EM. Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis. Ann. Rev Pathol Mech Dis. 2010;5:145-171.
Schwimmer JB, Pardee PE, Lavine JE, Blumkin AK, Cook S. Cardiovascular Risk Factors and the Metabolic Syndrome in Pediatric Nonalcoholic Fatty Liver Disease. Circulation. 2008;118(3):277-83.
Perazzo H, Poynard T, Dufour JF. The Interactions of Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases. Clin Liver Dis. 2014;18(1):233-48.
Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S, Benson JT, Enders FB, Angulo P. The natural history of non-alcoholic fatty liver disease in children: a followup study for up to 20 years. Gut. 2009;58(11):1538-44.
Erickson SK. Nonalcoholic fatty liver disease. J Lipid Res. 2009;50(Suppl):S412-S416.
Ferolla SM, Ferrari TC, Lima ML, Reis TO, Tavares-Jr WC, Couto OF, et al. Dietary patterns in Brazilian patients with nonalcoholic fatty liver disease: a crosssectional study. Clinics (Sao Paulo). 2013;68(1):11-17.
Cotrim HP, Parise ER, Oliveira CP, Leite N, Martinelli A, Galizzi J, et al. Nonalcoholic fatty liver disease in Brazil. Clinical and histological profile. Ann Hepatol. 2011;10(1):33-7.
Souza FIS, Amâncio OMS, Sarni ROS, Pitta TS, Fernandes AP, Fonseca FLA, et al. Doença hepática gordurosa não alcoólica em escolares obesos. Rev Paul Pediatr. 2008;26(2):136-41.
Soler GLN, Silva AWSM, Silva VCG, Teixeira RJ. Doença hepática gordurosa não-alcoólica:associação com síndrome metabólica e fatores de risco cardiovascular. Rev. SOCERJ. 2008;21(2):94-100.
Caranti DA, Lazzer S, Dâmaso AR, Agosti F, Zennaro R, de Mello MT, et al. Prevalence and risk factors of metabolic syndrome in Brazilian and Italian obese adolescents: a comparison study. Int J Clin Pract.2008;62(10):1526-32.
Angurana SK, Angurana RS. Prevalence of metabolic syndrome in adolescents: Reason to worry. Indian J Endocrinol Metab. 2013;17(6):1135-6.
Moraes ACF, Fulaz CS, Oliveira Netto ER, Reichert FF.Prevalência de síndrome metabólica em adolescentes:uma revisão sistemática. Cad Saúde Pública.2009;25(6):1195-202.
Campos L de A, Amancio OMS, Costa e Forti A.Impact of obesity on metabolic syndrome in Brazilian adolescents - a population-based study. Diabetes Care.2013;36(9):e139-40.
Stanley TL, Chen ML, Goodman E. The typology ofmetabolic syndrome in the transition to adulthood. J Clin Endocrinol Metab. 2014;99(3):1-9.
Instituto Brasileiro de Geografia e Estatística – IBGE.Pesquisa de Orçamentos Familiares - POF 2008-2009.Comunicação Social 27 de agosto de 2010 [acesso em 2014 Jan 4]. Disponível em: http://saladeimprensa.ibge.gov.br/index.phpoption=com_saladeimprensa&view=noticias&id=1&paginar=1&quantidade=10&pa gina=1&busca=1&Itemid=1719&data-inicio=&data-fim=&alvo=obesidade+na+adolescencia.
Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, et al. 2000 Centers for Disease Control (CDC) growth charts for the United States: methods and development. Vital Health Stat. 2002;11(246):1-190.
Marshall WA, Tanner JM. Variations in pattern of puberal changes in girls. Arch Dis Childh.1969;44(233):291-303.19. Marshall WA, Tanner JM. Variations in pattern of puberal changes in boys. Arch Dis Childh.1970;45(239):13-23.
Moll AJ. Esteatose hepática: avaliação por ultrasonografia. Informativo Med D’Or (RJ). 2006;6:6-7.
Saadeh S, Younossi ZM, Reme EM, Gramlich T, Ong JP, Hurley M, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterol.2002;123(3):745-50.
Diniz ALD, Tomé RAF, Debs CL, Carraro R, Roever LB, Pinto RMC. Avaliação da reprodutibilidade ultrassonográfica como método para medida da gordura abdominal e visceral. Radiol Bras. 2009;42(6):353–7.
Zimmet P, Alberti G, Kaufman F, Tajima N, Silink M, Arslanian S, et al. The metabolic syndrome in children and adolescents: the IDF consensus. Diabetes Voice.2007;52(4):29-32.
Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J. The Methabolic Syndrome: A Global Public Health Problem and A New Definition. J Athrosclerosis Thrombosis. 2005;15(6):295-300.
V Diretrizes Brasileiras de Dislipidemias e Prevenção da Aterosclerose. Arq Bras Cardiol. 2013;101(4Supl.1):1-22.
International Diabetes Federation – IDF. The IDF consensus worldwide definition of the metabolic syndrome [acesso em 2014 Jan 10]. April 14, 2005. Disponível em: http://www.idf.org/metabolicsyndrome
Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome: a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabetic Medicine. 2006;23(5):469–80.
Associação Brasileira para o Estudo da Obesidade e da Síndrome Metabólica - ABESO. Diretrizes brasileiras de obesidade 2009/2010 [acesso em 2014 Jan 20]. Disponível em: http://www.abeso.org.br/pdf/diretrizes_brasileiras_obesidade_2009_2010_1.pdf.
Van Grouw J, Volpe SL. Childhood obesity in America.Current Opinion in Endocrinology, Diabetes & Obesity.2013;20(5):396-400.
Travi MIC, Bastos PRHO, Pontes ERJC. Prevalência de sobrepeso, obesidade e circunferência abdominal alterada em escolares de 6 a 11 anos de idade em Campo Grande/MS. Rev Bras Promoç Saúde. 2011;24(1):54-62.
Balakrishnan PL. Identification of Obesity and Cardiovascular Risk Factors in Childhood and Adolescence. Pediatr Clin North Am. 2014;61(1):153-71.
Franks PW, Hanson RL, Knowler WC, Sievers ML, Bennett PH, Looker HC. Childhood obesity, other cardiovascular risk factors, and premature death. N Engl J Med. 2010;362(6):485-93.
Corey KE, Kaplan LM. Obesity and liver disease: the epidemic of the twenty-first century. Clin Liver Dis.2014;18(1):1-18.
Ramos MLM, Pontes ERJC, Ramos MLM, Barros VRSP. Sobrepeso e obesidade em escolares de 10 a 14 anos. Rev Bras Promoç Saúde. 2013;26(2):223-32.
Yilmaz Y, Younossi ZM. Obesity-Associated Nonalcoholic Fatty Liver Disease. Clin Liver Dis.2014;18(1):19-31.
Rizzo AC, Goldberg TB, Silva CC, Kurokawa CS, Nunes HR, Corrente JE. Metabolic syndrome risk factors in overweight, obese, and extremely obese Brazilian adolescents. Nutr J. 2013;12(19):1-9.
Barzin M, Asghari G, Hosseinpanah F, Mirmiran P, Azizi F. The association of anthropometric indices in adolescence with the occurrence of the metabolic syndrome in early adulthood. Pediatr Obes. 2013;8(3):170-7.
Fu JF, Shi HB, Liu LR, Jiang P, Wang CL, Liu XY. Non-alcoholic fatty liver disease: An early mediator predicting metabolic syndrome in obese children? World J Gastroenterol. 2011;17(6):735-42.
Fernandes MTB, Ferraro AA, Azevedo RA, Fagundes Neto U. Metabolic differences between male and female adolescents with non-alcoholic fatty liver disease, as detected by ultrasound. Acta Paediatrica.2010;99(8):1218-23.
Ford ES, Li C, Zhao G. Prevalence of the Metabolic Syndrome Among U.S. Adolescents Using the Definition From the International Diabetes Federation. Diabetes Care. 2008;31(3):587-9.
